Shockwave Medical (SWAV) Misses Q2 EPS by 7c

Shockwave Medical (NASDAQ: SWAV) reported Q2 EPS of $0.76, $0.07 worse than the analyst estimate of $0.83. Revenue for the quarter came in at $180.2 million versus the consensus estimate of $173.79 million.

For earnings history and earnings-related data on Shockwave Medical (SWAV) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Morgan Stanley Resumes Kohl's (KSS) at Underweight
• Intercontinental Exchange (ICE) PT Lowered to $208 at Raymond James, 'we view the risk/reward as attractive'